Selected article for: "ace receptor and acute respiratory syndrome sars"
Author: Ejaz, Hasan; Alsrhani, Abdullah; Zafar, Aizza; Javed, Humera; Junaid, Kashaf; Abdalla, Abualgasim E.; Abosalif, Khalid O.A.; Ahmed, Zeeshan; Younas, Sonia
Title: COVID-19 and comorbidities: Deleterious impact on infected patients
  • Cord-id: 19qx02x4
  • Document date: 2020_8_4
    • ID: 19qx02x4
    Snippet: The pandemic situation with the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from China has endangered human lives. Coronavirus disease 2019 (COVID-19) is presented with asymptomatic, mild, or severe pneumonia-like symptoms. COVID-19 patients with diabetes, chronic obstructive pulmonary disease (COPD), cardiovascular diseases (CVD), hypertension, malignancies, HIV, and other comorbidities could develop a life-threatening situation. SARS-CoV-2 utilizes ACE-2 receptors
    Document: The pandemic situation with the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from China has endangered human lives. Coronavirus disease 2019 (COVID-19) is presented with asymptomatic, mild, or severe pneumonia-like symptoms. COVID-19 patients with diabetes, chronic obstructive pulmonary disease (COPD), cardiovascular diseases (CVD), hypertension, malignancies, HIV, and other comorbidities could develop a life-threatening situation. SARS-CoV-2 utilizes ACE-2 receptors found at the surface of the host cells to get inside the cell. Certain comorbidities are associated with a strong ACE-2 receptor expression and higher release of proprotein convertase that enhance the viral entry into the host cells. The comorbidities lead to the COVID-19 patient into a vicious infectious circle of life and are substantially associated with significant morbidity and mortality. The comorbid individuals must adopt the vigilant preventive measure and requires scrupulous management. In this review, we rigorously focused on the impact of common morbidities in COVID-19 patients and recapitulated the management strategies with recent directions. We found limited resources describing the association of comorbidities in COVID-19; however, our review delineates the broader spectrum of comorbidities with COVID-19 patients.

    Search related documents:
    Co phrase search for related documents
    • abnormal liver and acute ards respiratory distress syndrome: 1
    • abnormal liver and acute infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • abnormal liver and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • abnormal liver and admission rate: 1, 2, 3
    • abnormal liver biochemistry and acute infection: 1, 2, 3, 4, 5
    • abnormal liver biochemistry and acute respiratory syndrome: 1, 2, 3, 4, 5
    • abnormal liver function and acute aki kidney injury: 1
    • abnormal liver function and acute infection: 1, 2, 3, 4, 5, 6, 7
    • abnormal liver function and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • abnormal liver function and admission rate: 1, 2
    • abnormal liver function test and acute respiratory syndrome: 1, 2, 3
    • accurate evaluation and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7
    • ace inhibitor and acute aki kidney injury: 1, 2, 3
    • ace inhibitor and acute ards respiratory distress syndrome: 1, 2, 3, 4
    • ace inhibitor and acute coronary syndrome: 1
    • ace inhibitor and acute infection: 1, 2, 3, 4, 5
    • ace inhibitor and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ace inhibitor and admission rate: 1
    • acute aki kidney injury and admission rate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12